Projects per year
Personal profile
Education
- 2003-2006 Ph.D., National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, University of London, London, UK
- 1987-1994 M.D., School of Medicine, College of Medicine, Taipei Medical University
Experience
- 2022.01- Dean, Research and Development, Taipei Medical University
- 2022.08-2022.10 Director, Research Center of Cancer Translational Medicine, Taipei Medical University
- 2020.08-2021.12 Vice Superintendent, Taipei Medical University Shuang Ho Hospital
- 2019.08-2021.12 Dean, Office of Human Research, Taipei Medical University
- 2019.10-2019.07 Director, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2018.08- Vice Director, Research Center of Thoracic Medicine, Taipei Medical University
- 2017.08- Professor, Department of Internal Medicine, Taipei Medical University
- 2017.08- Associate Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- 2017.08- Associate Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2015.08- Associate Professor, Master Program for Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014.08- Graduate Institute of Clinical Medicine, Taipei Medical University
- 2014.03-2017.07 Associate Professor, Department of Internal Medicine, Taipei Medical University
- 2013.07-2013.07 Attending Physician, Division of Chest Medicine, Linkou Chang Gung Memorial Hospital
- 2007.08-2013.07 Adjunct Assistant Professor, School of Medicine, Chang Gung University
- 2007.07-2013.06 Attending Physician, Division of Chest Medicine, Linkou Chang Gung Memorial Hospital
- 2001.07-2007.06 Attending Physician, Division of Chest Medicine, Linkou Chang Gung Memorial Hospital
Awards
- 2019 Excellent Clinical Trial Leader Award, Taipei Medical University
Research Interests
- Epigenetic regulation of inflammation in airway disease
- Cancer Immunology
- Tumor microenvironment
Fingerprint
- 1 Similar Profiles
Network
-
-
胸腔醫學學門規劃研究推動計畫
1/1/23 → 12/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
Investigation of Pm2.5-Mediated Emphysema Phenotype through Itih Dysregulation in Copd( I )
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
Unravelling the Role of Tigit in the Transition of Immune Tolerance and Exhaustion Natural Killer Cells in Copd Patients (1/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討潛在天然產物對PM2.5藉氧化壓力引發細胞老化之影響
7/1/22 → 2/28/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
AIM2 upregulation promotes metastatic progression and PD-L1 expression in lung adenocarcinoma
Zheng, J. Q., Lin, C. H., Lee, H. H., Chang, W. M., Li, L. J., Su, C. Y., Lee, K. Y., Chiu, H. W. & Lin, Y. F., Jan 2023, In: Cancer Science. 114, 1, p. 306-320 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Associations of the distance-saturation product and low-attenuation area percentage in pulmonary computed tomography with acute exacerbation in patients with chronic obstructive pulmonary disease
Chen, K-Y., Kuo, H-Y., Lee, K-Y., Feng, P-H., Wu, S-M., Chuang, H-C., Chen, T-T., Sun, W-L., Tseng, C-H., Liu, W-T., Cheng, W-H., Majumdar, A., Stettler, M., Tsai, C-Y. & Ho, S-C., Jan 2023, In: Frontiers in Medicine. 9, 1047420.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study
Yang, J. C. H., Su, W. C., Chiu, C. H., Shiah, H. S., Lee, K. Y., Hsia, T. C., Uno, M., Crawford, N., Terakawa, H., Chen, W. C., Takayama, G., Hsu, C., Hong, Y., Saintilien, C., McGill, J. & Chang, G. C., 2023, (Accepted/In press) In: Investigational New Drugs. 41, 2, p. 306-316 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Hippo signaling pathway contributes to air pollution exposure-induced emphysema in ageing rats
Laiman, V., Hsiao, T-C., Fang, Y-T., Chen, Y-Y., Lo, Y-C., Lee, K-Y., Chen, T-T., Chen, K-Y., Ho, S-C., Wu, S-M., Chen, J-K., Heriyanto, D. S., Chung, K. F., Ho, K-F., Chuang, K-J., Chang, J-H. & Chuang, H-C., Jun 15 2023, In: Journal of Hazardous Materials. 452, p. 131188 1 p.Research output: Contribution to journal › Article › peer-review
-
Impact of lifetime air pollution exposure patterns on the risk of chronic disease
Tsai, C. Y., Su, C. L., Wang, Y. H., Wu, S. M., Liu, W. T., Hsu, W. H., Majumdar, A., Stettler, M., Chen, K. Y., Lee, Y. T., Hu, C. J., Lee, K. Y., Tsuang, B. J. & Tseng, C. H., Jul 2023, In: Environmental Research. 229, 115957.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Suppressor of variegation 3–9 homologue 1 impairment and neutrophil-skewed systemic inflammation are associated with comorbidities in COPD
Chen, T. (Creator), Wu, S. (Creator), Chen, K. (Creator), Tseng, C. (Creator), Ho, S. (Creator), Chuang, H. (Creator), Feng, P. (Creator), Liu, W. (Creator), Han, C. (Creator), Huang, E. W. (Creator), Yeh, Y. (Creator) & Lee, K. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5645020.v1, https://springernature.figshare.com/collections/Suppressor_of_variegation_3_9_homologue_1_impairment_and_neutrophil-skewed_systemic_inflammation_are_associated_with_comorbidities_in_COPD/5645020/1
Dataset
-
Prolonged exposure to traffic-related particulate matter and gaseous pollutants implicate distinct molecular mechanisms of lung injury in rats
Jheng, Y. (Creator), Putri, D. U. (Creator), Chuang, H. (Creator), Lee, K. (Creator), Chou, H. (Creator), Wang, S. (Creator) & Han, C. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5484461.v1, https://doi.org/10.6084%2Fm9.figshare.c.5484461.v1
Dataset